The Isocitrate Dehydrogenase [NADP] Cytoplasmic pipeline drugs market research report outlays comprehensive information on the Isocitrate Dehydrogenase [NADP] Cytoplasmic targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Isocitrate Dehydrogenase [NADP] Cytoplasmic pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Oncology, and Hematological Disorders which include the indications Solid Tumor, Bile Duct Cancer (Cholangiocarcinoma), and Cytopenia. It also reviews key players involved in Isocitrate Dehydrogenase [NADP] Cytoplasmic targeted therapeutics development with respective active and dormant or discontinued products.
The Isocitrate Dehydrogenase [NADP] Cytoplasmic pipeline targets constitutes close to 12 molecules. Out of which, approximately ten molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Pre-Registration, Filing rejected/ Withdrawn, Phase III, Phase II, Phase I, IND/ CTA Filed, and Preclinical stages are 1, 1, 2, 3, 1, 1, and 1 respectively. Similarly, the universities portfolio in Phase II, and Preclinical comprises 1, and 1 molecule.
Isocitrate Dehydrogenase [NADP] Cytoplasmic overview
IDH1 is a NADP(+)-dependent isocitrate dehydrogenase found in the cytoplasm and peroxisomes. This enzyme in peroxisomes is involved in the regeneration of NADPH for intraperoxisomal reductions, such as the conversion of 2, 4-dienoyl-CoAs to 3-enoyl-CoAs, as well as in peroxisomal reactions that consume 2-oxoglutarate, namely the alpha-hydroxylation of phytanic acid. The cytoplasmic enzyme serves a significant role in cytoplasmic NADPH production.
For a complete picture of Isocitrate Dehydrogenase [NADP] Cytoplasmic’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.